{
    "organizations": [],
    "uuid": "8b6faba6abc752f01a5d999105a3298a01dfa833",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nemaura-announces-positive-results/brief-nemaura-announces-positive-results-for-its-sugarbeat-european-clinical-program-idUSFWN1PQ1EJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Nemaura Announces Positive Results For Its Sugarbeat European Clinical Program",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 31, 2018 / 6:34 PM / in 24 minutes BRIEF-Nemaura Announces Positive Results For Its Sugarbeat European Clinical Program Reuters Staff \nJan 31 (Reuters) - Nemaura Medical Inc: \n* NEMAURA ANNOUNCES POSITIVE RESULTS FOR ITS SUGARBEATÂ® EUROPEAN CLINICAL PROGRAM \n* NEMAURA MEDICAL - SUGARBEAT IS EXPECTED TO LAUNCH IN UK, FOLLOWED BY OTHER TERRITORIES UPON ACHIEVING CE APPROVAL, WHICH IS ANTICIPATED IN COMING MONTHS \n* NEMAURA MEDICAL INC - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S. \n* NEMAURA MEDICAL - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S., AND FOR USE OF SUGARBEAT IN CRITICAL CARE SETTINGS Source text for Eikon: Further company coverage:",
    "published": "2018-01-31T20:34:00.000+02:00",
    "crawled": "2018-01-31T20:54:48.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "announces",
        "positive",
        "result",
        "sugarbeat",
        "european",
        "clinical",
        "program",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "nemaura",
        "medical",
        "inc",
        "nemaura",
        "announces",
        "positive",
        "result",
        "european",
        "clinical",
        "program",
        "nemaura",
        "medical",
        "sugarbeat",
        "expected",
        "launch",
        "uk",
        "followed",
        "territory",
        "upon",
        "achieving",
        "ce",
        "approval",
        "anticipated",
        "coming",
        "month",
        "nemaura",
        "medical",
        "inc",
        "additional",
        "clinical",
        "study",
        "planned",
        "sugarbeat",
        "fda",
        "approval",
        "nemaura",
        "medical",
        "additional",
        "clinical",
        "study",
        "planned",
        "sugarbeat",
        "fda",
        "approval",
        "use",
        "sugarbeat",
        "critical",
        "care",
        "setting",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}